Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Major Manufacturers Covered in This Report
• 1.3 Market Segment by Type
  • 1.3.1 Global Pharma Ophthalmic Market Size Growth Rate by Type (2019-2025)
  • 1.3.2 Retinal Disorders Drugs
  • 1.3.3 Allergic, Inflammatory and Infective Drugs
  • 1.3.4 Glaucoma Drugs
  • 1.3.5 Dry Eye Drugs
  • 1.3.6 Other Ophthalmic Drugs
• 1.4 Market Segment by Application
  • 1.4.1 Global Pharma Ophthalmic Market Share by Application (2019-2025)
  • 1.4.2 Glaucoma
  • 1.4.3 Dry Eye Syndrome
  • 1.4.4 Retinal Diseases
  • 1.4.5 Other Ophthalmic Indications
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Growth Trends

• 2.1 Global Pharma Ophthalmic Market Size
  • 2.1.1 Global Pharma Ophthalmic Revenue 2014-2025
  • 2.1.2 Global Pharma Ophthalmic Sales 2014-2025
• 2.2 Pharma Ophthalmic Growth Rate by Regions
  • 2.2.1 Global Pharma Ophthalmic Sales by Regions 2014-2019
  • 2.2.2 Global Pharma Ophthalmic Revenue by Regions 2014-2019
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers

3 Market Share by Manufacturers

• 3.1 Pharma Ophthalmic Sales by Manufacturers
  • 3.1.1 Pharma Ophthalmic Sales by Manufacturers 2014-2019
  • 3.1.2 Pharma Ophthalmic Sales Market Share by Manufacturers 2014-2019
• 3.2 Revenue by Manufacturers
  • 3.2.1 Pharma Ophthalmic Revenue by Manufacturers (2014-2019)
  • 3.2.2 Pharma Ophthalmic Revenue Share by Manufacturers (2014-2019)
  • 3.2.3 Global Pharma Ophthalmic Market Concentration Ratio (CR5 and HHI)
• 3.3 Pharma Ophthalmic Price by Manufacturers
• 3.4 Key Manufacturers Pharma Ophthalmic Plants/Factories Distribution and Area Served
• 3.5 Date of Key Manufacturers Enter into Pharma Ophthalmic Market
• 3.6 Key Manufacturers Pharma Ophthalmic Product Offered
• 3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Sales and Revenue for Each Type
  • 4.1.1 Retinal Disorders Drugs Sales and Revenue (2014-2019)
  • 4.1.2 Allergic, Inflammatory and Infective Drugs Sales and Revenue (2014-2019)
  • 4.1.3 Glaucoma Drugs Sales and Revenue (2014-2019)
  • 4.1.4 Dry Eye Drugs Sales and Revenue (2014-2019)
  • 4.1.5 Other Ophthalmic Drugs Sales and Revenue (2014-2019)
• 4.2 Global Pharma Ophthalmic Sales Market Share by Type
• 4.3 Global Pharma Ophthalmic Revenue Market Share by Type
• 4.4 Pharma Ophthalmic Price by Type

5 Market Size by Application

• 5.1 Overview
• 5.2 Global Pharma Ophthalmic Sales by Application

6 United States

• 6.1 United States Pharma Ophthalmic Breakdown Data by Company
• 6.2 United States Pharma Ophthalmic Breakdown Data by Type
• 6.3 United States Pharma Ophthalmic Breakdown Data by Application

7 European Union

• 7.1 European Union Pharma Ophthalmic Breakdown Data by Company
• 7.2 European Union Pharma Ophthalmic Breakdown Data by Type
• 7.3 European Union Pharma Ophthalmic Breakdown Data by Application

8 China

• 8.1 China Pharma Ophthalmic Breakdown Data by Company
• 8.2 China Pharma Ophthalmic Breakdown Data by Type
• 8.3 China Pharma Ophthalmic Breakdown Data by Application

9 Rest of World

• 9.1 Rest of World Pharma Ophthalmic Breakdown Data by Company
• 9.2 Rest of World Pharma Ophthalmic Breakdown Data by Type
• 9.3 Rest of World Pharma Ophthalmic Breakdown Data by Application
• 9.4 Rest of World Pharma Ophthalmic Breakdown Data by Countries
  • 9.4.1 Rest of World Pharma Ophthalmic Sales by Countries
  • 9.4.2 Rest of World Pharma Ophthalmic Revenue by Countries
  • 9.4.3 Japan
  • 9.4.4 Korea
  • 9.4.5 India
  • 9.4.6 Southeast Asia

10 Company Profiles

• 10.1 Novartis
  • 10.1.1 Novartis Company Details
  • 10.1.2 Company Description and Business Overview
  • 10.1.3 Sales, Revenue and Market Share of Pharma Ophthalmic
  • 10.1.4 Pharma Ophthalmic Product Introduction
  • 10.1.5 Novartis Recent Development
• 10.2 Allergan
  • 10.2.1 Allergan Company Details
  • 10.2.2 Company Description and Business Overview
  • 10.2.3 Sales, Revenue and Market Share of Pharma Ophthalmic
  • 10.2.4 Pharma Ophthalmic Product Introduction
  • 10.2.5 Allergan Recent Development
• 10.3 Roche
  • 10.3.1 Roche Company Details
  • 10.3.2 Company Description and Business Overview
  • 10.3.3 Sales, Revenue and Market Share of Pharma Ophthalmic
  • 10.3.4 Pharma Ophthalmic Product Introduction
  • 10.3.5 Roche Recent Development
• 10.4 Valeant
  • 10.4.1 Valeant Company Details
  • 10.4.2 Company Description and Business Overview
  • 10.4.3 Sales, Revenue and Market Share of Pharma Ophthalmic
  • 10.4.4 Pharma Ophthalmic Product Introduction
  • 10.4.5 Valeant Recent Development
• 10.5 Regeneron
  • 10.5.1 Regeneron Company Details
  • 10.5.2 Company Description and Business Overview
  • 10.5.3 Sales, Revenue and Market Share of Pharma Ophthalmic
  • 10.5.4 Pharma Ophthalmic Product Introduction
  • 10.5.5 Regeneron Recent Development
• 10.6 Santen
  • 10.6.1 Santen Company Details
  • 10.6.2 Company Description and Business Overview
  • 10.6.3 Sales, Revenue and Market Share of Pharma Ophthalmic
  • 10.6.4 Pharma Ophthalmic Product Introduction
  • 10.6.5 Santen Recent Development
• 10.7 Bayer
  • 10.7.1 Bayer Company Details
  • 10.7.2 Company Description and Business Overview
  • 10.7.3 Sales, Revenue and Market Share of Pharma Ophthalmic
  • 10.7.4 Pharma Ophthalmic Product Introduction
  • 10.7.5 Bayer Recent Development
• 10.8 Pfizer
  • 10.8.1 Pfizer Company Details
  • 10.8.2 Company Description and Business Overview
  • 10.8.3 Sales, Revenue and Market Share of Pharma Ophthalmic
  • 10.8.4 Pharma Ophthalmic Product Introduction
  • 10.8.5 Pfizer Recent Development
• 10.9 Senju
  • 10.9.1 Senju Company Details
  • 10.9.2 Company Description and Business Overview
  • 10.9.3 Sales, Revenue and Market Share of Pharma Ophthalmic
  • 10.9.4 Pharma Ophthalmic Product Introduction
  • 10.9.5 Senju Recent Development
• 10.10 Akorn
  • 10.10.1 Akorn Company Details
  • 10.10.2 Company Description and Business Overview
  • 10.10.3 Sales, Revenue and Market Share of Pharma Ophthalmic
  • 10.10.4 Pharma Ophthalmic Product Introduction
  • 10.10.5 Akorn Recent Development

11 Value Chain and Sales Channels Analysis

• 11.1 Value Chain Analysis
• 11.2 Sales Channels Analysis
  • 11.2.1 Pharma Ophthalmic Sales Channels
  • 11.2.2 Pharma Ophthalmic Distributors
• 11.3 Pharma Ophthalmic Customers

12 Market Forecast

• 12.1 Global Pharma Ophthalmic Sales and Revenue Forecast 2019-2025
• 12.2 Global Pharma Ophthalmic Sales Forecast by Type
• 12.3 Global Pharma Ophthalmic Sales Forecast by Application
• 12.4 Pharma Ophthalmic Forecast by Regions
  • 12.4.1 Global Pharma Ophthalmic Sales Forecast by Regions 2019-2025
  • 12.4.2 Global Pharma Ophthalmic Revenue Forecast by Regions 2019-2025
• 12.5 United States Market Forecast
• 12.6 European Union Market Forecast
• 12.7 China Market Forecast
• 12.8 Rest of World
  • 12.8.1 Japan
  • 12.8.2 Korea
  • 12.8.3 India

13 Research Findings and Conclusion

14 Appendix

• 14.1 Research Methodology
  • 14.1.1 Methodology/Research Approach
    • 14.1.1.1 Research Programs/Design
    • 14.1.1.2 Market Size Estimation
    • 14.1.1.3 Market Breakdown and Data Triangulation
  • 14.1.2 Data Source
    • 14.1.2.1 Secondary Sources
    • 14.1.2.2 Primary Sources
• 14.2 Author Details

In 2019, the market size of Pharma Ophthalmic is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Pharma Ophthalmic.

This report studies the global market size of Pharma Ophthalmic, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Pharma Ophthalmic sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
Novartis
Allergan
Roche
Valeant
Regeneron
Santen
Bayer
Pfizer
Senju
Akorn

Market Segment by Product Type
Retinal Disorders Drugs
Allergic, Inflammatory and Infective Drugs
Glaucoma Drugs
Dry Eye Drugs
Other Ophthalmic Drugs

Market Segment by Application
Glaucoma
Dry Eye Syndrome
Retinal Diseases
Other Ophthalmic Indications

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Pharma Ophthalmic status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Pharma Ophthalmic manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Pharma Ophthalmic are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025